Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96


Adenosine Induces EBV Lytic Reactivation through ADORA1 in EBV-Associated Gastric Carcinoma.

Choi SJ, Ryu E, Lee S, Huh S, Shin YS, Kang BW, Kim JG, Cho H, Kang H.

Int J Mol Sci. 2019 Mar 14;20(6). pii: E1286. doi: 10.3390/ijms20061286.


Cordycepin is a novel chemical suppressor of Epstein-Barr virus replication.

Ryu E, Son M, Lee M, Lee K, Cho JY, Cho S, Lee SK, Lee YM, Cho H, Sung GH, Kang H.

Oncoscience. 2014 Dec 18;1(12):866-881. eCollection 2014.


Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.

Reusch JA, Nawandar DM, Wright KL, Kenney SC, Mertz JE.

J Virol. 2015 Feb;89(3):1731-43. doi: 10.1128/JVI.02781-14. Epub 2014 Nov 19.


Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus.

Gorres KL, Daigle D, Mohanram S, McInerney GE, Lyons DE, Miller G.

MBio. 2016 Mar 1;7(2):e00113. doi: 10.1128/mBio.00113-16.


Inhibition of Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells by dietary sulforaphane.

Wu CC, Chuang HY, Lin CY, Chen YJ, Tsai WH, Fang CY, Huang SY, Chuang FY, Lin SF, Chang Y, Chen JY.

Mol Carcinog. 2013 Dec;52(12):946-58. doi: 10.1002/mc.21926. Epub 2012 May 29.


Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication.

Wille CK, Nawandar DM, Panfil AR, Ko MM, Hagemeier SR, Kenney SC.

J Virol. 2013 Jan;87(2):935-50. doi: 10.1128/JVI.01790-12. Epub 2012 Nov 7.


Intracellular Iron Chelation by a Novel Compound, C7, Reactivates Epsteinā»Barr Virus (EBV) Lytic Cycle via the ERK-Autophagy Axis in EBV-Positive Epithelial Cancers.

Yiu SPT, Hui KF, Choi CK, Kao RYT, Ma CW, Yang D, Chiang AKS.

Cancers (Basel). 2018 Dec 11;10(12). pii: E505. doi: 10.3390/cancers10120505.


Differentiation-Dependent LMP1 Expression Is Required for Efficient Lytic Epstein-Barr Virus Reactivation in Epithelial Cells.

Nawandar DM, Ohashi M, Djavadian R, Barlow E, Makielski K, Ali A, Lee D, Lambert PF, Johannsen E, Kenney SC.

J Virol. 2017 Mar 29;91(8). pii: e02438-16. doi: 10.1128/JVI.02438-16. Print 2017 Apr 15.


Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma.

Hui KF, Ho DN, Tsang CM, Middeldorp JM, Tsao GS, Chiang AK.

Int J Cancer. 2012 Oct 15;131(8):1930-40. doi: 10.1002/ijc.27439. Epub 2012 Mar 8.


Luteolin inhibits Epstein-Barr virus lytic reactivation by repressing the promoter activities of immediate-early genes.

Wu CC, Fang CY, Hsu HY, Chen YJ, Chou SP, Huang SY, Cheng YJ, Lin SF, Chang Y, Tsai CH, Chen JY.

Antiviral Res. 2016 Aug;132:99-110. doi: 10.1016/j.antiviral.2016.05.007. Epub 2016 May 13.


Epstein-Barr Virus BZLF1-Mediated Downregulation of Proinflammatory Factors Is Essential for Optimal Lytic Viral Replication.

Li Y, Long X, Huang L, Yang M, Yuan Y, Wang Y, Delecluse HJ, Kuang E.

J Virol. 2015 Nov 4;90(2):887-903. doi: 10.1128/JVI.01921-15. Print 2016 Jan 15.


PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoter.

Lupey-Green LN, Moquin SA, Martin KA, McDevitt SM, Hulse M, Caruso LB, Pomerantz RT, Miranda JL, Tempera I.

Virology. 2017 Jul;507:220-230. doi: 10.1016/j.virol.2017.04.006. Epub 2017 Apr 26.


Identification of Novel Small Organic Compounds with Diverse Structures for the Induction of Epstein-Barr Virus (EBV) Lytic Cycle in EBV-Positive Epithelial Malignancies.

Choi CK, Ho DN, Hui KF, Kao RY, Chiang AK.

PLoS One. 2015 Dec 30;10(12):e0145994. doi: 10.1371/journal.pone.0145994. eCollection 2015.


The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1.

Robinson AR, Kwek SS, Kenney SC.

PLoS Pathog. 2012 Feb;8(2):e1002516. doi: 10.1371/journal.ppat.1002516. Epub 2012 Feb 9.


Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer.

Zhao J, Jin H, Cheung KF, Tong JH, Zhang S, Go MY, Tian L, Kang W, Leung PP, Zeng Z, Li X, To KF, Sung JJ, Yu J.

Cancer. 2012 Feb 15;118(4):924-36. doi: 10.1002/cncr.26184. Epub 2011 Jun 29.


Activation and repression of Epstein-Barr Virus and Kaposi's sarcoma-associated herpesvirus lytic cycles by short- and medium-chain fatty acids.

Gorres KL, Daigle D, Mohanram S, Miller G.

J Virol. 2014 Jul;88(14):8028-44. doi: 10.1128/JVI.00722-14. Epub 2014 May 7.


Rapamycin enhances lytic replication of Epstein-Barr virus in gastric carcinoma cells by increasing the transcriptional activities of immediate-early lytic promoters.

Wang M, Wu W, Zhang Y, Yao G, Gu B.

Virus Res. 2018 Jan 15;244:173-180. doi: 10.1016/j.virusres.2017.11.021. Epub 2017 Nov 21.


Cordycepin induces apoptosis in human bladder cancer cells via activation of A3 adenosine receptors.

Cao HL, Liu ZJ, Chang Z.

Tumour Biol. 2017 Jul;39(7):1010428317706915. doi: 10.1177/1010428317706915.


Supplemental Content

Support Center